Drug:
Reaction: ANAEMIA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940105 |
EU |
54 | 2 |
Septic shock, Drug tolerance decreased, Anaemia, Infection, Therapeutic product effect incomplete, Vena cava thrombosis, |
||||
VENETOCLAX, |
||||
| 2 | 26940149 |
US |
2 | |
Anaemia, Fatigue, |
||||
ROPEGINTERFERON ALFA-2B, |
||||
| 3 | 26940568 |
CA |
2 | |
Unevaluable event, Anaemia, |
||||
GLYCEROL PHENYLBUTYRATE, |
||||
| 4 | 26940694 |
EU |
55 | 1 |
Diabetic ketoacidosis, Neutropenia, Anaemia, Cytomegalovirus colitis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, |
||||
| 5 | 26940707 |
EU |
66 | 2 |
Bronchitis, Pneumonia, Arrhythmia, Anaemia, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ORAL SEMAGLUTIDE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, BISOPROLOL FUMARATE, |
||||
| 6 | 26940742 |
55 | 1 | |
Diabetic ketoacidosis, Neutropenia, Anaemia, Cytomegalovirus colitis, Drug ineffective, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, |
||||
| 7 | 26940880 |
EU |
72 | 2 |
Anaemia, Leukopenia, Neutropenia, Anaemia, Leukopenia, Neutropenia, Thrombocytopenia, Anaemia, Leukopenia, Neutropenia, Pancytopenia, Anaemia, Weight decreased, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 8 | 26941049 |
EU |
1 | |
Gastric ulcer, Anaemia, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, EDOXABAN TOSYLATE, |
||||
| 9 | 26941359 |
EU |
2 | |
Haematotoxicity, Anaemia, Nausea, |
||||
BEVACIZUMAB, OLAPARIB, |
||||
| 10 | 26941524 |
KH |
2 | |
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM, |
||||
| 11 | 26941836 |
US |
||
Thrombocytopenia, Anaemia, Neutropenia, Hypertension, Fatigue, Nausea, Myelodysplastic syndrome, Renal failure, |
||||
BEVACIZUMAB, OLAPARIB, NIRAPARIB, RUCAPARIB, |
||||
| 12 | 26942491 |
US |
45 | 2 |
Urinary tract infection, Upper respiratory tract infection, Headache, Arthralgia, Pyrexia, Protein urine present, Inflammatory marker increased, Blood immunoglobulin G increased, Blood immunoglobulin E increased, Serum ferritin increased, Anaemia, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, VEDOLIZUMAB, |
||||
| 13 | 26942582 |
50 | 1 | |
Kaposi^s sarcoma, Anaemia, Aplasia pure red cell, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE, |
||||
| 14 | 26942587 |
47 | 2 | |
Kaposi^s sarcoma, Anaemia, Cytomegalovirus colitis, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 15 | 26943088 |
EU |
1 | |
Anaemia, Eastern Cooperative Oncology Group performance status worsened, |
||||
ENZALUTAMIDE, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, PREGABALIN, DENOSUMAB, CALCIUM CARBONATE, ANTACID, PREDNISONE, FILGRASTIM, |
||||
| 16 | 26943192 |
36 | 2 | |
Anaemia, |
||||
DARATUMUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULFATE, |
||||
| 17 | 26943194 |
EU |
72 | 2 |
Faecaloma, Balance disorder, Brain fog, Malaise, Dizziness, Alopecia, Anaemia, Enteritis, Gastrointestinal inflammation, White blood cell count decreased, |
||||
FULVESTRANT, FULVESTRANT, ABEMACICLIB, |
||||
| 18 | 26943232 |
63 | 1 | |
Anaemia, |
||||
DARATUMUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULFATE, |
||||
| 19 | 26943235 |
55 | 1 | |
Bradycardia, Hypotension, Pyrexia, Lung infiltration, Respiratory failure, Shock, Pulmonary embolism, Dyspnoea, Syncope, Anaemia, Asthenia, Cardio-respiratory arrest, Aspiration, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 20 | 26943305 |
US |
29 | 2 |
Pain, Weight decreased, Diarrhoea, Anaemia, Condition aggravated, Infection, |
||||
SARILUMAB, |
||||
| 21 | 26943603 |
EU |
81 | 2 |
Anaemia, Granulocytopenia, |
||||
ZOLPIDEM TARTRATE, AMLODIPINE, VINORELBINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, IRON, PREDNISONE, |
||||
| 22 | 26943707 |
EU |
||
Clostridium difficile colitis, Dyspnoea, Pain, Condition aggravated, Inflammatory marker increased, Anaemia, Oedema peripheral, Pleural effusion, Respiratory failure, Serratia infection, General physical health deterioration, Swelling, Clostridium difficile infection, Laboratory test abnormal, Drug ineffective, |
||||
PANTOPRAZOLE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PREGABALIN, PREGABALIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, RAMIPRIL, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, CYCLOSPORINE, CALCIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM GLUCONATE, IRON SUCROSE, TORSEMIDE, ERYTHROPOIETIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, |
||||
| 23 | 26943865 |
US |
56 | 1 |
Blood urea increased, Blood creatinine increased, Glomerular filtration rate decreased, Creatinine renal clearance decreased, Blood bicarbonate decreased, Protein total decreased, Anaemia, Fatigue, |
||||
SPARSENTAN, SPARSENTAN, SPARSENTAN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 24 | 26943995 |
EU |
93 | 2 |
Cardiac arrest, Dysphonia, Poisoning, Coagulopathy, Anaemia, Full blood count abnormal, Abdominal distension, Hepatic failure, |
||||
EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, TRANEXAMIC ACID, TRANEXAMIC ACID, TRANEXAMIC ACID, TRANEXAMIC ACID, |
||||
| 25 | 26944333 |
GB |
2 | |
Respiratory failure, Acute kidney injury, Electrocardiogram QT prolonged, Electrocardiogram PR prolongation, Atrioventricular block, Differential white blood cell count abnormal, Anaemia, |
||||
CLOZAPINE, |
||||
| 26 | 26944542 |
41 | 1 | |
Drug ineffective, Anaemia, Hypotension, |
||||
SPARSENTAN, |
||||
| 27 | 26944658 |
CA |
49 | 2 |
Blood pressure abnormal, Varices oesophageal, Blood creatinine increased, Cystitis, Nausea, Vomiting, Dehydration, Anaemia, Alanine aminotransferase decreased, |
||||
ELAFIBRANOR, DAPAGLIFLOZIN, ORAL SEMAGLUTIDE, CARVEDILOL, |
||||
| 28 | 26944839 |
85 | ||
Anaemia, Haematuria, |
||||
RIVAROXABAN, |
||||
| 29 | 26945148 |
EU |
39 | 2 |
Anaemia, Pulseless electrical activity, Overdose, |
||||
METHYLENE BLUE, EPINEPHRINE, |
||||
| 30 | 26945267 |
EU |
85 | 1 |
Anaemia, Lower gastrointestinal haemorrhage, Product prescribing error, |
||||
RIVAROXABAN, APIXABAN, |
||||
| 31 | 26945440 |
EU |
85 | 1 |
Anaemia, Lower gastrointestinal haemorrhage, Product prescribing error, |
||||
RIVAROXABAN, RIVAROXABAN, APIXABAN, |
||||
| 32 | 26945701 |
JP |
52 | 2 |
Anaemia, Haematochezia, Diverticulum intestinal haemorrhagic, Portal vein thrombosis, Haemobilia, |
||||
PACLITAXEL, PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, LANSOPRAZOLE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 33 | 26945760 |
GB |
2 | |
Anaemia, |
||||
CLOZAPINE, |
||||
| 34 | 26945837 |
US |
2 | |
Weight increased, Anaemia, Abdominal distension, Rash, Bone pain, |
||||
ABALOPARATIDE, IRON, |
||||
| 35 | 26945942 |
US |
31 | 1 |
Urine abnormality, Fatigue, Anaemia, |
||||
SPARSENTAN, PANTOPRAZOLE, ROSUVASTATIN, FLUOXETINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 36 | 26946596 |
US |
2 | |
Anaemia, |
||||
ABALOPARATIDE, |
||||
| 37 | 26947271 |
US |
2 | |
Anaemia, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE, AMOXICILLIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, IRON, |
||||
| 38 | 26947639 |
US |
21 | |
Anaemia, Off label use, |
||||
RUXOLITINIB, ROMIPLOSTIM, ERYTHROPOIETIN, |
||||
| 39 | 26947643 |
US |
18 | |
Anaemia, Platelet count decreased, Off label use, |
||||
RUXOLITINIB, TOFACITINIB, TOFACITINIB CITRATE, |
||||
| 40 | 26947718 |
US |
2 | |
Influenza, Anaemia, Vitamin D increased, Injection site erythema, Injection site bruising, Injection site pain, Blood calcium increased, |
||||
ABALOPARATIDE, OLOPATADINE HYDROCHLORIDE, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, BUDESONIDE, CALCIUM, BIOTIN, MAGNESIUM, CETIRIZINE HCL, CETIRIZINE, ERGOCALCIFEROL, |
||||
| 41 | 26934094 |
CA |
69 | 1 |
Arthritis, Hypoaesthesia, Oxygen saturation decreased, Product use issue, Thermal burn, Weight decreased, Body temperature decreased, Insomnia, Weight increased, Dry eye, Micturition disorder, Oedema peripheral, Ligament rupture, Blood pressure increased, Nerve compression, Gingival ulceration, Musculoskeletal stiffness, Blood pressure fluctuation, Pain in extremity, Joint range of motion decreased, Arthralgia, Blood pressure decreased, Mass, Infusion related reaction, Rash, Skin abrasion, Peripheral swelling, Pain, Dysuria, Paraesthesia, Skin papilloma, Blood pressure diastolic decreased, Dry skin, Neck pain, Skin discolouration, Blood pressure systolic increased, Cystitis bacterial, Blood pressure diastolic abnormal, Inflammation, Mouth ulceration, Fall, Anaemia, Rib fracture, Drug ineffective, Musculoskeletal stiffness, Back pain, Ill-defined disorder, Blood pressure systolic abnormal, Heart rate decreased, Pruritus, Osteoarthritis, Dry throat, Arthralgia, Arthralgia, Arthralgia, Pain, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CELECOXIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FOLIC ACID, |
||||
| 42 | 26934238 |
38 | 2 | |
Bronchiectasis, Atelectasis, Anaemia, Infection protozoal, Pneumonia, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 43 | 26935017 |
US |
2 | |
Atrial fibrillation, White blood cell count decreased, Platelet count decreased, Anaemia, Myalgia, Bone pain, Arthralgia, Rash, Stomatitis, Blood creatinine increased, |
||||
OSIMERTINIB, |
||||
| 44 | 26935026 |
CN |
56 | 1 |
Anaemia, Pneumonia, Hypokalaemia, Arrhythmia, Hypokalaemia, Hypokalaemia, Deep vein thrombosis, Ascites, Anaemia, Hypocalcaemia, Anaemia, Anaemia, Weight decreased, Anaemia, Hypocalcaemia, Decreased appetite, Hypocalcaemia, Hypocalcaemia, Supraventricular tachycardia, Anaemia, Platelet count decreased, Hypocalcaemia, White blood cell count decreased, Hypocalcaemia, Neutrophil count decreased, Anaemia, Decreased appetite, Sinus tachycardia, Anaemia, Pyrexia, Hypocalcaemia, Insomnia, Hypocalcaemia, Platelet count decreased, Hypoproteinaemia, Infection, Anaemia, Hypocalcaemia, Platelet count decreased, White blood cell count decreased, Anaemia, Hypocalcaemia, Platelet count decreased, Hypocalcaemia, Hypersensitivity, Anaemia, Anaemia, Hypocalcaemia, Constipation, Anaemia, Platelet count decreased, Hypocalcaemia, Oedema peripheral, Platelet count decreased, Nausea, Vomiting, Anaemia, Hypocalcaemia, Platelet count decreased, Constipation, Hypocalcaemia, Pelvic fluid collection, Diarrhoea, Dysuria, Hypocalcaemia, |
||||
SOTORASIB, SOTORASIB, |
||||
| 45 | 26935134 |
US |
66 | 1 |
Anaemia, Lymphocyte count decreased, |
||||
TEMOZOLOMIDE, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN AND CODEINE, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LEVETIRACETAM, |
||||
| 46 | 26935349 |
EU |
80 | 2 |
Contusion, Mouth haemorrhage, Subcutaneous haematoma, Anaemia, International normalised ratio increased, Off label use, |
||||
ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, CHLORHEXIDINE GLUCONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TIOTROPIUM BROMIDE, BISOPROLOL FUMARATE, FUROSEMIDE, PANTOPRAZOLE, SPIRONOLACTONE, URSODIOL, URSOSIOL, |
||||
| 47 | 26935797 |
CN |
76 | 1 |
Upper gastrointestinal haemorrhage, Conjunctival pallor, Diverticulum intestinal, Palpitations, Atrioventricular block, Dry mouth, Listless, Nausea, Faeces soft, Intestinal obstruction, Neuropathy peripheral, Discomfort, Throat lesion, Haematemesis, Asthenia, Gastric ulcer, Gastric ulcer haemorrhage, Dizziness, Hyperhidrosis, Deep vein thrombosis, Arrhythmia, Renal impairment, Pyrexia, Pain, Decreased appetite, Anaemia, Abdominal tenderness, Fatigue, Gastric haemorrhage, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 48 | 26936055 |
US |
88 | 2 |
Ulcer haemorrhage, Anaemia, Arthritis, Vision blurred, Bone density decreased, Heart rate irregular, Headache, Mobility decreased, Myalgia, Bacterial test positive, High density lipoprotein decreased, Blood calcium decreased, Blood creatinine increased, |
||||
DENOSUMAB, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM, TELMISARTAN, |
||||
| 49 | 26936154 |
JP |
50 | 2 |
Malignant neoplasm progression, Anaemia, Malaise, |
||||
BELZUTIFAN, |
||||
| 50 | 26936169 |
EU |
85 | 1 |
Anaemia, Off label use, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 51 | 26936194 |
CN |
||
Neutropenia, Thrombocytopenia, Anaemia, Hypoalbuminaemia, Hypokalaemia, Infection, Hypoalbuminaemia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin increased, |
||||
RITUXIMAB, LENALIDOMIDE, ZANUBRUTINIB, |
||||
| 52 | 26936382 |
39 | 2 | |
Anaemia, Overdose, |
||||
METHYLENE BLUE, METHYLENE BLUE, METHYLENE BLUE, EPINEPHRINE, ADRENALINUM, SODIUM NITRITE, |
||||
| 53 | 26936505 |
58 | 2 | |
Gastrointestinal haemorrhage, Melaena, Anaemia, |
||||
APIXABAN, APIXABAN, |
||||
| 54 | 26936515 |
EU |
83 | 2 |
Accidental overdose, Thrombocytopenia, Anaemia, Neutropenia, Mucosal inflammation, Rash, |
||||
METHOTREXATE SODIUM, PREDNISONE, FOLIC ACID, ESCITALOPRAM OXALATE, ESCITALOPRAM, |
||||
| 55 | 26936904 |
US |
||
Small intestinal obstruction, Prostate cancer, Anaemia, Abdominal adhesions, Blood iron decreased, Blood phosphorus decreased, Product dose omission issue, |
||||
RUXOLITINIB, |
||||
| 56 | 26936955 |
IR |
38 | 2 |
Infection protozoal, Bronchiectasis, Atelectasis, Pneumonia, Anaemia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 57 | 26937355 |
GB |
2 | |
Anaemia, |
||||
CLOZAPINE, |
||||
| 58 | 26937462 |
US |
58 | |
Full blood count decreased, Anaemia, Decreased appetite, Insomnia, Wrong technique in product usage process, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 59 | 26937563 |
US |
||
Lymphopenia, Hypoalbuminaemia, Anaemia, Diarrhoea, Hepatic failure, Haemorrhage, Embolism, Liver function test abnormal, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 60 | 26938105 |
CN |
||
Leukopenia, Neutropenia, Thrombocytopenia, Anaemia, Decreased appetite, Fatigue, Hypertension, Palmar-plantar erythrodysaesthesia syndrome, Proteinuria, Neuropathy peripheral, Transaminases increased, Mouth ulceration, Stomatitis, Abdominal pain, Diarrhoea, Hyperbilirubinaemia, Blood lactate dehydrogenase increased, Blood alkaline phosphatase increased, Gamma-glutamyltransferase increased, Hypoproteinaemia, Dysphagia, Dysphonia, Hypothyroidism, Hyperthyroidism, Rash, Hepatitis, Pruritus, Pneumonia, Infusion related reaction, Nephritis, |
||||
ATEZOLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), NIVOLUMAB, |
||||
| 61 | 26938450 |
EU |
21 | 2 |
Oedema peripheral, Blood pressure increased, Hypotension, Constipation, Haemorrhage, Anaemia, Blood fibrinogen decreased, |
||||
DEXMEDETOMIDINE, ALBUTEROL SULFATE, ALBUTEROL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, TRANEXAMIC ACID, CAPTOPRIL, |
||||
| 62 | 26938859 |
US |
76 | 1 |
Anaemia, |
||||
POMALIDOMIDE, POMALIDOMIDE, |
||||
| 63 | 26939153 |
US |
87 | 2 |
Hypoacusis, Anaemia, |
||||
ABALOPARATIDE, |
||||
| 64 | 26939309 |
US |
72 | 2 |
Febrile neutropenia, Tumour lysis syndrome, Neutropenia, Differentiation syndrome, Thrombocytopenia, Sepsis, Electrocardiogram QT prolonged, Anaemia, Blood disorder, Infection, Pneumonia, |
||||
IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, |
||||
| 65 | 26939325 |
US |
84 | 2 |
Haemorrhage, Malignant neoplasm progression, Anaemia, Thrombocytopenia, |
||||
IVOSIDENIB, IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, |
||||
| 66 | 26939800 |
JP |
75 | 2 |
Anaemia, Hypoxia, |
||||
BELZUTIFAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, AMLODIPINE, SACUBITRIL AND VALSARTAN, CARVEDILOL, |
||||
| 67 | 26943525 |
55 | 2 | |
Anaemia, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 68 | 26931321 |
CN |
61 | 2 |
Hepatic function abnormal, Pneumonia, Aortic valve incompetence, Tricuspid valve incompetence, Hepatic function abnormal, Mycoplasma infection, Hyperthyroidism, Hepatic function abnormal, Hepatic cyst, Anaemia, Chest discomfort, Hypoalbuminaemia, Blood glucose increased, Rash, Hyponatraemia, Hepatic function abnormal, Hypoalbuminaemia, Hepatic function abnormal, Hypoalbuminaemia, Hepatic function abnormal, Hypoalbuminaemia, Hyperuricaemia, Uterine leiomyoma, Neutrophil count decreased, Neutrophil count decreased, Hepatic function abnormal, Anaemia, Hepatic function abnormal, |
||||
SOTORASIB, |
||||
| 69 | 26931612 |
CN |
82 | 1 |
Hepatic function abnormal, Jaundice, Respiratory failure, Altered state of consciousness, Acidosis, Hepatic function abnormal, Jaundice, Urinary tract infection, Pain in extremity, Anaemia, Urinary tract infection, Constipation, Urinary tract infection, Hypoalbuminaemia, |
||||
SOTORASIB, |
||||
| 70 | 26931667 |
EU |
||
Septic shock, Off label use, Metabolic disorder, Fatigue, Mental disorder, Atrial fibrillation, Injury, Neutropenia, Urinary tract infection, Angiopathy, COVID-19, Benign neoplasm, Infusion related reaction, Renal disorder, COVID-19 pneumonia, Dyspnoea, Poisoning, Procedural complication, Nausea, Vision blurred, Neoplasm malignant, Neoplasm, Dry eye, Anaemia, Oedema peripheral, Arthralgia, Skin disorder, Hypertension, Cyst, Urinary tract disorder, Eye irritation, Pneumonia, Malnutrition, Diarrhoea, Cough, Infestation, Polyp, General symptom, Cardiac disorder, Spinal disorder, Investigation abnormal, Gastrointestinal disorder, Nervous system disorder, Respiratory disorder, Musculoskeletal disorder, Adverse event, Lymphatic disorder, Eye disorder, Administration site reaction, Mediastinal disorder, Blood disorder, Infection, Connective tissue disorder, |
||||
IBRUTINIB, RITUXIMAB, |
||||
| 71 | 26931937 |
EU |
77 | 1 |
Thrombocytopenia, Asthenia, Anaemia, |
||||
PEMBROLIZUMAB, CARBOPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 72 | 26932271 |
MK |
67 | 1 |
Thrombocytopenia, Nephropathy toxic, Immune-mediated hypothyroidism, Anaemia, |
||||
DURVALUMAB, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 73 | 26932360 |
EU |
53 | 1 |
Head and neck cancer, Anaemia, Product ineffective for unapproved use, Product use in unapproved indication, Drug ineffective, |
||||
PREGABALIN, PREGABALIN, |
||||
| 74 | 26932566 |
EU |
52 | 2 |
Heavy menstrual bleeding, Anaemia, |
||||
RIVAROXABAN, RIVAROXABAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, APIXABAN, |
||||
| 75 | 26933079 |
CA |
72 | 2 |
Malignant neoplasm progression, Fall, Contusion, Asthenia, Hospitalisation, Muscular weakness, Hypertension, Blood potassium decreased, Angioplasty, Malignant neoplasm progression, Gastric cancer, Headache, Migraine, Myalgia, Abdominal pain, Flatulence, Faeces discoloured, Nausea, Alopecia, Decreased appetite, Weight decreased, Breast discolouration, Insomnia, Pain in extremity, Off label use, Arthralgia, Diarrhoea, Abdominal pain upper, Off label use, Sinusitis, Eye infection, Anaemia, Pancreatic disorder, Vomiting, Nausea, Faeces discoloured, Abdominal pain upper, Polyp, Urinary tract infection, Fatigue, Diarrhoea, Abdominal distension, Stomach mass, Abdominal pain, Nausea, Vomiting, Diarrhoea, Fatigue, Polyp, Diarrhoea, Haemorrhoidal haemorrhage, Pain, Loss of personal independence in daily activities, Conjunctival laceration, Fall, Joint injury, Skin abrasion, Contusion, Pain, Fatigue, Pain, Nausea, Vomiting, Diarrhoea, Fall, Limb injury, Eye irritation, Walking aid user, Entropion, Asthenia, Fatigue, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANSOPRAZOLE, CLONAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CHOLESTYRAMINE, |
||||
| 76 | 26933880 |
CN |
||
Cardiac failure, Neuropathy peripheral, Pyrexia, Dyspnoea, Headache, Anaemia, Neutrophil count decreased, Platelet count decreased, Hypertension, Infection, Off label use, Tumour marker decreased, |
||||
DARATUMUMAB, DARATUMUMAB, |
||||
| 77 | 26933952 |
JP |
68 | 1 |
Febrile neutropenia, Neutrophil count decreased, White blood cell count decreased, Anaemia, Platelet count decreased, Incorrect drug administration rate, |
||||
TRABECTEDIN, TRABECTEDIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 78 | 26926691 |
US |
67 | 2 |
Seizure, Blood sodium decreased, Headache, Platelet count increased, Laboratory test abnormal, Anaemia, |
||||
IBRUTINIB, IBRUTINIB, ALLOPURINOL, BUPROPION, FUROSEMIDE, |
||||
| 79 | 26926693 |
CN |
65 | 1 |
Immune-mediated lung disease, Pneumonia fungal, Respiratory failure, Malignant neoplasm progression, Anaemia, Cardio-respiratory arrest, |
||||
NIVOLUMAB, NIVOLUMAB, CISPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 80 | 26927154 |
EU |
77 | 1 |
Anaemia, Asthenia, Thrombocytopenia, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, PEMBROLIZUMAB, CARBOPLATIN, |
||||
| 81 | 26927174 |
CN |
68 | 1 |
Platelet count decreased, Platelet count decreased, Anaemia, Platelet count decreased, Anaemia, |
||||
SOTORASIB, |
||||
| 82 | 26927317 |
US |
86 | 2 |
Knee arthroplasty, Tricuspid valve incompetence, Carotid artery occlusion, Left ventricular failure, Hypothyroidism, Dementia Alzheimer^s type, Mitral valve incompetence, Arteriosclerosis coronary artery, Type IIa hyperlipidaemia, Carotid artery stenosis, Type 2 diabetes mellitus, Fall, Hip arthroplasty, Alcohol abuse, Aortic valve stenosis, Essential hypertension, Back pain, Anaemia of chronic disease, Muscular weakness, Cough, Rhinitis allergic, Vitamin D deficiency, Nicotine dependence, Anaemia, Lumbosacral plexopathy, Peripheral vascular disorder, Constipation, Intervertebral disc degeneration, Cardiomegaly, Physical examination abnormal, Respiratory disorder, Vitamin B complex deficiency, Osteoarthritis, Cardiovascular symptom, Arthralgia, |
||||
DENOSUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CELECOXIB, ATORVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 83 | 26927330 |
US |
64 | 2 |
Syncope, Blindness transient, Dyspnoea, Anaemia, Fatigue, Nausea, Therapy interrupted, Blood creatinine increased, Glomerular filtration rate decreased, Product dose omission in error, |
||||
OLAPARIB, OLAPARIB, OLAPARIB, |
||||
| 84 | 26927373 |
US |
5 | 2 |
Gastrointestinal toxicity, Abdominal discomfort, Nausea, Diarrhoea, Anaemia, Fatigue, Blood iron decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, PEGFILGRASTIM, |
||||
| 85 | 26927374 |
JP |
76 | 2 |
Anaemia, Dizziness, Nausea, Oesophageal haemorrhage, Discoloured vomit, |
||||
ENTACAPONE, ENTACAPONE, SELEGILINE HYDROCHLORIDE, ZONISAMIDE, ROTIGOTINE, MAGNESIUM OXIDE, |
||||
| 86 | 26927539 |
CN |
||
Neutropenia, Febrile neutropenia, Anaemia, Thrombocytopenia, Pneumonia, Sepsis, Bacteraemia, Cardiac failure, Arrhythmia, Mucosal inflammation, Diarrhoea, Peripheral sensorimotor neuropathy, Fatigue, Asthenia, Death, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
| 87 | 26927710 |
GB |
2 | |
Diverticulitis, Anaemia, Rheumatoid arthritis, |
||||
UPADACITINIB, |
||||
| 88 | 26927784 |
VN |
||
Diarrhoea, Nausea, Fatigue, Vomiting, Alanine aminotransferase increased, Aspartate aminotransferase increased, Myalgia, Arthralgia, Anaemia, Rash, |
||||
CERITINIB, CERITINIB, |
||||
| 89 | 26928647 |
JP |
8 | 2 |
Anaemia, Platelet count decreased, Off label use, |
||||
MACITENTAN, SELEXIPAG, |
||||
| 90 | 26928855 |
EU |
86 | 1 |
Shock haemorrhagic, Anaemia, Melaena, |
||||
RIVAROXABAN, |
||||
| 91 | 26929033 |
CN |
||
Neutrophil count decreased, White blood cell count decreased, Anaemia, Platelet count decreased, Lymphocyte count decreased, Alanine aminotransferase increased, Nausea, Vomiting, Constipation, Asthenia, Diarrhoea, Pruritus, Aspartate aminotransferase increased, Electrocardiogram QT prolonged, Decreased appetite, |
||||
TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, CARBOPLATIN, DOXORUBICIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 92 | 26929067 |
JP |
9 | 1 |
Traumatic intracranial haemorrhage, Deep dissecting haematoma, Shock, Cardio-respiratory arrest, Fall, Anaemia, Skin necrosis, Haematoma infection, |
||||
PRASUGREL HYDROCHLORIDE, |
||||
| 93 | 26929114 |
KR |
45 | 2 |
Platelet count decreased, White blood cell count decreased, Anaemia, Neutrophil count decreased, |
||||
NIRAPARIB, DESVENLAFAXINE SUCCINATE, AMISULPRIDE, ZOLPIDEM TARTRATE, |
||||
| 94 | 26929630 |
EU |
63 | 1 |
General physical health deterioration, Clostridium difficile infection, Laboratory test abnormal, Drug ineffective, Clostridium difficile colitis, Dyspnoea, Pain, Condition aggravated, Inflammatory marker increased, Anaemia, Oedema peripheral, Pleural effusion, Respiratory failure, Serratia infection, |
||||
PREGABALIN, PREGABALIN, RAMIPRIL, PANTOPRAZOLE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, TORSEMIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, CYCLOSPORINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CALCIUM GLUCONATE, IRON SUCROSE, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, ERYTHROPOIETIN, |
||||
| 95 | 26930123 |
EU |
82 | 2 |
Eructation, Pulmonary hypertension, Hiatus hernia, Inflammatory marker increased, Hepatic cyst, Gait disturbance, Coronary artery disease, Decreased appetite, Urinary tract infection, Acute kidney injury, Aplastic anaemia, Urinary retention, Wound dehiscence, Arterial haemorrhage, Diverticulum intestinal, Pancreatic steatosis, Myocardial infarction, Haemarthrosis, Tricuspid valve incompetence, Myelodysplastic syndrome, Impaired healing, General physical health deterioration, Cardiogenic shock, Faecaloma, Left ventricular dysfunction, Abdominal discomfort, Arthralgia, Femoral hernia incarcerated, Fall, Mitral valve incompetence, Dyspnoea, Wound infection pseudomonas, Postoperative wound infection, Escherichia infection, Joint dislocation, Aortic valve stenosis, Cardiovascular disorder, Anaemia, Gastrointestinal haemorrhage, Lymphatic fistula, Seroma, Groin pain, |
||||
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, PANTOPRAZOLE, EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, SIMVASTATIN, TORSEMIDE, TORSEMIDE, CLOPIDOGREL BISULFATE, AMIODARONE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VALSARTAN, VALSARTAN ORAL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENTANYL, ESOMEPRAZOLE, ESOMEPRAZOLE, TORSEMIDE, TORSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, FOLIC ACID, LACTULOSE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, |
||||
| 96 | 26930499 |
CN |
59 | 1 |
Pneumonia, Liver injury, Hypokalaemia, Hypokalaemia, Aortic arteriosclerosis, Hyperadrenocorticism, Pneumonia, Pneumonia, Hyperkalaemia, Pneumonia, Pneumonia, Pneumonia, Pneumonia, Diarrhoea, Drug eruption, Infection, Diarrhoea, Nausea, Platelet count increased, Hypoproteinaemia, Dyspepsia, Renal cyst, Anaemia, Oedema peripheral, Infection, Diarrhoea, Hypocalcaemia, Diarrhoea, Hyperparathyroidism, Proteinuria, Malnutrition, Anaemia, Anaemia, Anaemia, Fatigue, |
||||
SOTORASIB, |
||||
| 97 | 26930888 |
EU |
69 | 2 |
Major depression, Hepatic cytolysis, Neutropenia, Anaemia, |
||||
ZOLEDRONIC ACID, PALBOCICLIB, PALBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 98 | 26930980 |
EU |
70 | 1 |
Pseudomonas infection, Bronchitis, Anaemia, Hypokalaemia, Gastroenteritis cryptosporidial, Sepsis syndrome, Joint effusion, Pleural effusion, |
||||
DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, |
||||
| 99 | 26921385 |
US |
2 | |
Illness, Anaemia, |
||||
TIRZEPATIDE, |
||||
| 100 | 26921440 |
US |
1 | |
White blood cell count increased, Anaemia, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
